drugset / Trial / NCT04986813

Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery

NCT04986813

Phase 4 Completed 100 enrolled Jaspreet Singh
RandomizedParallel-groupSingle-blindPrevention

Summary

This study was done to evaluate the efficacy of Tranexamic Acid (TXA) in reducing blood transfusion requirement in patients of lower limb trauma undergoing surgery.

Timeline

Start
2017-04-01
Primary completion
2018-08-31
Completion
2018-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 g Intravenous

Indications

No indication recorded.